We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+4.94%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.98B
AUM Growth
+$857M
(+14%)
Cap. Flow
+$784M
Cap. Flow
% of AUM
11.24%
Top 10 Holdings %
Top 10 Hldgs %
16.48%
Holding
878
New
205
Increased
124
Reduced
98
Closed
184
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qorvo
QRVO
|
+$153M |
| 2 |
ASML
ASML
|
+$117M |
| 3 |
Revolution Medicines
RVMD
|
+$58.1M |
| 4 |
Meta Platforms (Facebook)
META
|
+$49.6M |
| 5 |
Intuitive Surgical
ISRG
|
+$48.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teradyne
TER
|
+$132M |
| 2 |
Qualcomm
QCOM
|
+$77.3M |
| 3 |
Abbott
ABT
|
+$69.2M |
| 4 |
Booking.com
BKNG
|
+$67.7M |
| 5 |
KLA
KLAC
|
+$63.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.18% |
| 2 | Technology | 29.45% |
| 3 | Communication Services | 6.73% |
| 4 | Industrials | 6.43% |
| 5 | Financials | 4.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Aclaris Therapeutics
ACRS
$799M
| – | – |
-594,768
| Closed | -$10.7M |
|
702
AMN Healthcare
AMN
$1.29B
| – | – |
-15,277
| Closed | -$1.75M |
|
703
Appian
APPN
$2.05B
| – | – |
-19,867
| Closed | -$1.84M |
|
704
Arvinas
ARVN
$586M
| – | – |
-128,250
| Closed | -$10.5M |
|
705
Aurora
AUR
$13.3B
| – | – |
-534,607
| Closed | -$5.31M |
|
706
Avantor
AVTR
$9.07B
| – | – |
-777,854
| Closed | -$31.8M |
|
707
BARK
BARK
$86.3M
| – | – |
-7,020
| Closed | -$963K |
|
|
708
Booking.com
BKNG
$150B
| – | – |
-713,175
| Closed | -$67.7M |
|
709
Cadence Design Systems
CDNS
$94.3B
| – | – |
-35,700
| Closed | -$5.41M |
|
710
Certara
CERT
$1.17B
| – | – |
-82,183
| Closed | -$2.72M |
|
711
Check Point Software Technologies
CHKP
$12.6B
| – | – |
-35,299
| Closed | -$3.99M |
|
712
Ciena
CIEN
$58.4B
| – | – |
-368,786
| Closed | -$18.9M |
|
|
CLLS
713
Cellectis
CLLS
$290M
| – | – |
-93,132
| Closed | -$1.17M |
|
|
CMPS
714
Compass Pathways
CMPS
$1.56B
| – | – |
-12,613
| Closed | -$377K |
|
715
Compass
COMP
$9.09B
| – | – |
-53,402
| Closed | -$708K |
|
716
Charles River Laboratories
CRL
$11.2B
| – | – |
-12,426
| Closed | -$5.13M |
|
717
Cisco
CSCO
$472B
| – | – |
-317,831
| Closed | -$17.3M |
|
718
Cue Biopharma
CUE
$116M
| – | – |
-9,504
| Closed | -$4.15M |
|
719
Diodes
DIOD
$3.98B
| – | – |
-92,654
| Closed | -$8.39M |
|
720
Doximity
DOCS
$3.95B
| – | – |
-20,612
| Closed | -$1.66M |
|
721
Dynatrace
DT
$13.2B
| – | – |
-190,287
| Closed | -$13.5M |
|
722
DaVita
DVA
$14.7B
| – | – |
-24,291
| Closed | -$2.82M |
|
723
DoubleVerify
DV
$1.82B
| – | – |
-25,838
| Closed | -$883K |
|
724
Encompass Health
EHC
$10.9B
| – | – |
-110,762
| Closed | -$6.61M |
|
725
eHealth
EHTH
$46M
| – | – |
-16,751
| Closed | -$678K |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Woodline Partners held 878 positions worth $6.98B, up 14% from $6.12B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $784M of net new capital in Q4 2021, opening 205 new positions and adding to 124 existing holdings. Its largest new stake was Qorvo: 963,210 shares worth $151M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was KLA, an estimated $63.2M trimmed.
- Woodline Partners's largest Q4 2021 buy was Qorvo: 963,210 shares worth $151M.
- Woodline Partners added most to ASML in Q4 2021, an estimated $117M increase.
- Woodline Partners's biggest Q4 2021 reduction was KLA, cutting an estimated $63.2M.
- Woodline Partners fully exited Teradyne in Q4 2021, selling an estimated $132M.
- Woodline Partners's ten largest holdings make up 16% of its $6.98B portfolio in Q4 2021.
- Woodline Partners opened 205 new positions and closed 184 in Q4 2021.
- Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.98B.
Based on Woodline Partners's 13F filing for Q4 2021, filed 14 Feb 2022.